WEE1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.829000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.239400E-01
Normal-vs-Stage2
7.413000E-01
Normal-vs-Stage3
2.482000E-01
Normal-vs-Stage4
4.461800E-01
Stage1-vs-Stage2
5.289700E-02
Stage1-vs-Stage3
1.257440E-01
Stage1-vs-Stage4
5.372700E-04
Stage2-vs-Stage3
2.180800E-03
Stage2-vs-Stage4
2.020900E-04
Stage3-vs-Stage4
6.3713999999937E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.539600E-01
Normal-vs-AfricanAmerican
7.585200E-01
Normal-vs-Asian
1.553040E-01
Caucasian-vs-AfricanAmerican
5.022200E-01
Caucasian-vs-Asian
1.612790E-01
AfricanAmerican-vs-Asian
3.196800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.978000E-01
Normal-vs-Female
6.637000E-01
Male-vs-Female
8.776000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.885400E-01
Normal-vs-Age(41-60Yrs)
7.872600E-01
Normal-vs-Age(61-80Yrs)
2.834600E-01
Normal-vs-Age(81-100Yrs)
2.020600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.763000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.070800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.956000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.117450E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.515100E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.025200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.762000E-01
Normal-vs-Daily Drinker
5.569000E-01
Normal-vs-Weekly Drinker
1.527210E-01
Normal-vs-Occasional Drinker
7.518000E-01
Normal-vs-Social Drinker
4.861800E-01
Non Drinker-vs-Daily Drinker
8.528800E-01
Non Drinker-vs-Weekly Drinker
1.527760E-01
Non Drinker-vs-Occasional Drinker
2.413600E-01
Non Drinker-vs-Social Drinker
7.227800E-01
Daily Drinker-vs-Weekly Drinker
1.209570E-01
Daily Drinker-vs-Occasional Drinker
9.025800E-02
Daily Drinker-vs-Social Drinker
8.233600E-01
Weekly Drinker-vs-Occasional Drinker
1.008490E-02
Weekly Drinker-vs-Social Drinker
1.969190E-01
Occasional Drinker-vs-Social Drinker
9.458300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.041800E-01
Normal-vs-Grade 2
4.598000E-02
Normal-vs-Grade 3
1.419780E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.534400E-01
Grade 1-vs-Grade 3
3.600400E-01
Grade 1-vs-Grade 4
3.041800E-01
Grade 2-vs-Grade 3
7.090200E-01
Grade 2-vs-Grade 4
4.598000E-02
Grade 3-vs-Grade 4
1.419780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.367600E-01
Normal-vs-NonDiabetic
6.661000E-01
Diabetic-vs-NonDiabetic
3.412400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.414400E-01
Normal-vs-NoPancreatitis
5.987400E-01
Pancreatitis-vs-NoPancreatitis
8.944200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.326800E-01
Normal-vs-N1
7.749000E-01
N0-vs-N1
3.081800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.399000E-01
Normal-vs-TP53-NonMutant
3.801800E-01
TP53-Mutant-vs-TP53-NonMutant
2.189500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
